Asthma/COPD:

Indications for Ipratropium Bromide Inhalation Solution:

Bronchospasm associated with chronic bronchitis and emphysema.

Adult Dosage:

500mcg orally by nebulization 3–4 times daily; separate doses by 6–8 hours.

Children Dosage:

Not established.

Ipratropium Bromide Inhalation Solution Contraindications:

Allergy to atropine or its derivatives.

Ipratropium Bromide Inhalation Solution Warnings/Precautions:

Not for primary treatment of acute attack. Avoid eyes. Narrow-angle glaucoma. GU obstruction. Pregnancy. Nursing mothers.

See Also:

Ipratropium Bromide Inhalation Solution Classification:

Anticholinergic.

Ipratropium Bromide Inhalation Solution Interactions:

Caution with other anticholinergics.

Adverse Reactions:

Bronchitis, COPD exacerbation, dyspnea, headache, anticholinergic effects; paradoxical bronchospasm, hypersensitivity reactions.

Generic Drug Availability:

HFA (NO); soln (YES)

How Supplied:

Inhaler—12.9g (200 inh); inhalation soln—contact supplier